Evaluation of palliative stenting for management of malignant urethral obstructions in dogs

Journal of the American Veterinary Medical Association

Volumn 229, Issue 2, 2006, Pages 226-234

  Weisse, Chick ^a   Berent, Allyson ^a   Todd, Kim ^a   Clifford, Craig ^c   Solomon, Jeffrey ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c RED BANK VETERINARY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; BLOOD CLOT; CYSTOURETHROGRAPHY; DOG; FEMALE; FLUOROSCOPY; HYPOTONIC BLADDER; MALE; NONHUMAN; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; STENT; TREATMENT OUTCOME; URETHRA STENOSIS; URINE INCONTINENCE;

ANIMALS; BALLOON DILATATION; CARCINOMA, TRANSITIONAL CELL; DOG DISEASES; DOGS; FEMALE; FLUOROSCOPY; MALE; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; STENTS; TREATMENT OUTCOME; URETHRAL NEOPLASMS; URETHRAL OBSTRUCTION; URINARY INCONTINENCE;

ANIMALIA; CANIS FAMILIARIS;

EID: 33746064079     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.229.2.226     Document Type: Article

References (20)

1. Norris AM, Laing EJ, Valli VEO, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992;16:145-153.
2. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. Urol Oncol 2000;5:47-59.
3. Mutsaers AJ, Widmer WR, Knapp DW. Canine transitional cell carcinoma. J Vet Intern Med 2003;17:136-144.
4. Stone EA, Withrow SJ, Page RL, et al. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 1988;17:147-153.
5. Smith JD, Vaden SL, Stone EA, et al. Management and complications following trigonal-colonic anastomosis in a dog: five-year evaluation. J Am Anim Hosp Assoc 1996;32:29-35.
6. Fries CL, Binnington AG, Valli VE, et al. Enterocystoplasty with cystectomy and subtotal intracapsular prostatectomy in male dogs. Vet Surg 1991;20:104-112.
7. Bell FW, Klausner JS, Hayden DW, et al. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970-1987). J Am Vet Med Assoc 1991;199:1623-1630.
8. Goldsmid SE, Bellenger CR. Urinary incontinence after prostatectomy in dogs. Vet Surg 1991;20:253-256.
9. Mann FA, Barrett RJ, Henderson RA. Use of a retained urethral catheter in three dogs with prostatic neoplasia. Vet Surg 1992; 21:342-347.
10. Liptak JM, Brutscher SP, Monnet E, et al. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg 2004;33:505-516.
11. Stiffler KS, McCrackin Stevenson MA, Cornell KK, et al. Clinical use of low-profile cystostomy tubes in four dogs and a cat. J Am Vet Med Assoc 2003;223:325-329.
12. Latal D, Mraz J, Zerhau P, et al. Nitinol urethral stents: long-term results in dogs. Urol Res 1994;22:295-300.
13. Shin JH, Song HY, Choi CG, et al. Tissue hyperplasia: influence of a paclitaxel-eluting covered stent-preliminary study in a canine urethral model. Radiology 2005;234:438-444.
14. Dobben RL, Wright KC, Dolenz K, et al. Prostatic urethra dilatation with the gianturco self-expanding metallic stent: a feasibility study in cadaver specimens and dogs. AJR Am J Roentgenol 1991;156:757-761.
15. Arnold S, Weber U. Urethral sphincter mechanism incompetence in male dogs. Curr Vet Ther XIII 2000;11:896-899.
16. Basinger RR, Rawlings CA, Barsanti JA, et al. Urodynamic alterations after prostatectomy in dogs without clinical prostatic disease. Vet Surg 1987;16:405-410.
17. Hardie EM, Barsanti JA, Rawlings CA. Complications of prostatic surgery. J Am Anim Hosp Assoc 1984;20:50-56.
18. Basinger RR, Rawlings CA, Barsanti JA, et al. Urodynamic alterations associated with clinical prostatic diseases and prostatic surgery in 23 dogs. J Am Anim Hosp Assoc 1989;25: 385-392.
19. Diethylstilbestrol (DES). In: Plumb DC, ed. Veterinary drug handbook, pocket edition. 4th ed. White Bear Lake, Minn: PharmaVet Publishing, 2002;269-271.
20. Henry CJ, McCaw DL, Turnquist SE, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Can Res 2003;9: 906-911.